Netra Mandena, daughter of US-based billionaire Rama Raju Mantena, is marrying tech co-founder Vamsi Gadiraju in a lavish Udaipur wedding. ...

Udaipur is gearing up for one of 2025’s most extravagant weddings, hosted by pharma tycoon Raj Mantena. With global VIPs, Bollywood stars, ...

Ryaltris is a fixed-dose combination of olopatadine, an antihistamine and mometasone furoate, a corticosteroid to treat the symptoms of all...

Donald Trump announced new tariffs. The US will impose a 100 per cent tariff on specific pharmaceutical products from October 1. There is a...

The Nifty Pharma index was trading 0.36 per cent up at 22186.4.

President Droupadi Murmu made a historic visit to Timor-Leste, marking the first-ever presidential visit from India to the Asian country. S...

The Ambanis hosted an extravagant pre-wedding celebration for Anant and Radhika, spanning three opulent days. The guest list included lumin...

Glenmark had gross debt of ₹3,765 crore as of June 30, 2022. The company over the years accumulated debt to fund its innovation-led R&D and...

Glenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.

Sales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...

The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used p...

The drug industry is facing threats from unexpected rivals such as Google and Samsung, while the auto sector is grappling with new-age neme...

India sales of the pharma firm jumped 17 per cent to Rs 1,807 crore whereas US finished dosage sales rose 19 per cent YoY to $580 million i...

Company did not elaborate on the summons but such a grand subpoena by the DoJ anti-trust division is usually issued to check anti-competiti...

Monaco government invited Indian companies to invest in various sectors, including information and technology, pharmaceuticals and realty.

A minority shareholder of Taro Pharma on Monday rejected Sun Pharma's sweetened offer price of $39.5 a share for a buyout, signalling furth...

Guardian Point Capital, one of the minority shareholders of Israeli firm Taro Pharma, has asked Sun Pharma to revise $24.50 share price off...